info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Multidrug-Resistant Bacteria Market By Drug Class (Beta-lactam Combinations, Oxazolidinones & Glycopeptides, Tetracyclines & Derivatives, Polymyxins, Others [Phage Therapy, CRISPR-based Antimicrobials, Novel Peptides]); By Pathogen Type (Gram-Negative Bacteria, Gram-Positive Bacteria, Anaerobic and Atypical Pathogens); By Application Setting (Hospital-Acquired Infections, Community-Acquired Infections, Long-Term Care & Post-Acute Care, Military, Emergency, and Trauma Care); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Multidrug-Resistant Bacteria Market: AMR Mortality, Gram-Negative Resistance, and New Antibiotic Approvals Rebuild the Value of Anti-Infective Innovation

The Global Multidrug-Resistant Bacteria Market was valued at USD 13.5 billion in 2025 and is projected to reach US... Read More

Published Date: JUN-2026 | No Of Pages:154 | $ 4485

Skin Microbiome Market By Product Type (Probiotic Skincare, Prebiotic Skincare, Postbiotic Formulations, Microbiome Therapeutics); By Application (Cosmetic Skincare, Medical Dermatology, Personal Hygiene); By End User (Consumers, Dermatology Clinics, Pharmaceutical & Biotech Companies, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Skin Microbiome Market valued at USD 1.98 billion in 2024 and projected to reach USD 4.52 billion by 2030 at 14.6% CAGR, driven by skincare innova... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Sterilization Equipment Market By Product Type (Steam Sterilizers, Low-Temperature Sterilizers, Ethylene Oxide (EtO) Sterilizers, Radiation-Based Sterilizers); By Application (Healthcare Facilities, Pharmaceutical & Biotechnology, Food Processing, Cosmetics Manufacturing); By End User (Hospitals & Clinics, Contract Sterilization Providers, Medical Device Manufacturers, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sterilization Equipment Market valued at USD 13.2 billion in 2024 and reaching USD 19.8 billion by 2030 at 7.1% CAGR, driven by medical devicesRead More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Gastric Ulcer Treatment Market By Treatment Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blockers, H2-Receptor Antagonists, Antibiotic Combination Therapies, Bismuth-Based Therapies, Mucosal Protective Agents, Antacids, Endoscopic Treatment, Surgical Treatment); By Application (Helicobacter pylori-Associated Gastric Ulcers, NSAID-Induced Gastric Ulcers, Bleeding Gastric Ulcers, Refractory Gastric Ulcers, Recurrent Gastric Ulcers, Perforated Gastric Ulcers, Stress-Related Gastric Ulcers); By End User (Hospitals, Gastroenterology Clinics, Ambulatory Endoscopy Centers, Primary Care Clinics, Retail Pharmacies, Hospital and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Gastric Ulcer Treatment Market: Resistance-Aware H. pylori Therapy, Follow-Up Care, and Payer Access Redirect Revenue

The Global Gastric Ulcer Treatment Market was valued at USD 5.63 billion in 2025 and is projected to reach USD 8.57 billion by 2032, growing at a CAGR... Read More

Published Date: JUL-2026 | No Of Pages:195 | $ 4485

VMAT2 Inhibitors Market by Application (Parkinson’s Disease, Huntington’s Disease, Tardive Dyskinesia, Other Neurological Disorders); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global VMAT2 Inhibitors Market is set to grow significantly, driven by advancements in neurological therapeutics and an increasing understanding of neurological disorders. As of 2024, the market ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Alkylating Agents Market By Product Type (Nitrogen Mustards, Alkyl Sulfonates, Nitrosoureas, Triazenes, Others); By Route of Administration (Intravenous, Oral); By Application (Hematological Malignancies, Solid Tumors, Others); By End User (Hospitals, Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alkylating Agents Market is projected to witness a robust CAGR of 6.4%, valued at USD 7.1 billion in 2024, and expected to reach USD 10.4 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Povidone Iodine Market By Product Type (Scrub Solution, Ointment, Gargle, Swabs, Others); By Formulation (Liquid, Powder, Ointment, Spray); By Application (Wound Care, Surgical Disinfection, Oral Care, Gynecological Hygiene, Dermatology); By End User (Hospitals, Clinics, Pharmacies, NGOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Povidone Iodine Market is projected to reach approximately USD 920 million by 2030, growing from an estimated USD 640 million in 2024, at a steady Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Parenteral Packaging Market By Product Type (Vials, Prefilled Syringes, Ampoules, Cartridges, IV Bags); By Material (Glass, Plastic); By Drug Type (Vaccines, Biologics, Small Molecule Injectables); By End User (Pharmaceutical Companies, CMOs, Hospitals, Home Healthcare Settings); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Parenteral Packaging Market growing at 7.7% CAGR, from USD 15.8 billion in 2024 to USD 24.6 billion by 2030, driven by pharmaceutical packagingRead More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Pneumoconiosis Market By Disease Type (Coal Workers’ Pneumoconiosis, Silicosis, Asbestosis); By Diagnostic Tool (Chest X-ray, High-Resolution CT, Pulmonary Function Tests, AI Screening Software); By Treatment Modality (Oxygen Therapy, Bronchodilators & Anti-inflammatory Drugs, Anti-fibrotic Agents, Pulmonary Rehabilitation); By End User (Occupational Health Clinics, Public Hospitals, Respiratory Care Centers, Mobile Screening Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pneumoconiosis Market valued at USD 2.3 billion in 2024 and projected to reach USD 3.1 billion by 2030 at 5.1% CAGR, driven by occupational lung d... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Tularemia Therapeutics Market By Product Type (Antibiotics, Novel Therapeutics); By Route of Administration (Oral, Intravenous, Intramuscular); By End User (Hospitals, Public Health Agencies, Military/Biodefense, Research Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Tularemia Therapeutics Market: Updated Treatment Guidance, Outbreak Volatility, and Biodefence Preparedness Reshape Commercial Value

The Global Tularemia Therapeutics Market is estimated at USD 155.0 million in 2025 and is projected t... Read More

Published Date: JUL-2026 | No Of Pages:167 | $ 4485

Galectin Inhibitor Therapeutics Market By Type (Small Molecule Inhibitors, Monoclonal Antibodies, Glycomimetics); By Indication (Oncology, Fibrosis, Inflammatory and Autoimmune Disorders); By Route of Administration (Oral, Intravenous); By End User (Specialty Cancer Centers, Hepatology Clinics, Academic Research Hospitals, Community Oncology Networks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Galectin Inhibitors Market Advances Across Fibrosis, Oncology & Immune-Mediated Disease Pipelines (Last Updated on: June-2026)

The Global Galectin Inhibitor Therapeutics Market will witness a robust CAGR of 24.8%, valued at USD 0.67 b... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Powered Morcellator Market By Product Type (Reusable Morcellators, Disposable Morcellators); By Application (Gynecology, Urology, General Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Powered Morcellator Market is poised to expand steadily, with a projected CAGR of 6.8%, valued at USD 1.2 billion in 2024 and expected to reach USD 1.8 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Cannabis Pharmaceuticals Market By Product Type (Cannabidiol [CBD], Tetrahydrocannabinol [THC], Combination Cannabinoids, Synthetic Cannabinoids); By Route of Administration (Oral, Inhalation, Topical, Sublingual); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Pharmaceuticals Market valued at USD 3.9 billion in 2024 and projected to reach USD 10.3 billion by 2030 at 17.6% CAGR, driven by pharmac... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

WNT Signaling Pathway Inhibitor Market By Type of Inhibitor (Small Molecule Inhibitors, Monoclonal Antibodies, Other Biologics); By Application (Oncology, Bone Diseases, Neurodegenerative Diseases); By End-User (Hospitals, Research Institutions, Specialized Cancer Centers, Diagnostic Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Wnt Signaling Inhibitors Market Advances Through Precision Oncology Pipelines Targeting β-Catenin, DKK1 and PORCN Biology (Last Updated on: June-2026)

The Global WNT Signaling Pathway Inhibitor Market is projected to grow from USD 2.8 billion in 2024 to USD 6.1 b... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Nasal Aspirate Testing Market By Test Type (Molecular Testing, Immunoassay Testing, Culture-Based Testing); By End User (Hospitals, Diagnostic Laboratories, Pediatric Clinics, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nasal Aspirate Testing Market valued at USD 1.2 billion in 2024 and projected to reach USD 2.4 billion by 2030 at 7.5% CAGR, driven by diagnostic ... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Lymphangioleiomyomatosis Market By Type (Sporadic LAM, TSC-Associated LAM); By Treatment (Sirolimus, Everolimus, Supportive Therapy, Lung Transplantation); By Diagnostic Modality (HRCT Imaging, VEGF-D Testing, Genetic Testing); By End User (Tertiary Hospitals, Pulmonology Clinics, Diagnostic Labs, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lymphangioleiomyomatosis Market valued at USD 428 million in 2024 and projected to reach USD 610 million by 2030 at 6.1% CAGR, driven by rare dise... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Autoimmune Hepatitis Market By Disease Type (Type 1 Autoimmune Hepatitis, Type 2 Autoimmune Hepatitis, Seronegative Autoimmune Hepatitis); By Treatment Type (Corticosteroids, Conventional Immunosuppressants, Biologics & Targeted Therapies, Liver Transplant Interventions); By Diagnosis & Monitoring Method (Autoantibody Testing, IgG Quantification, Liver Function Testing, Liver Biopsy, Fibrosis Assessment Tools); By End User (Tertiary Care Hospitals, Specialty Clinics, Diagnostic Laboratories, Transplant Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Autoimmune Hepatitis Market: Lifelong Immunosuppression and Steroid-Sparing Innovation Expand a Focused Rare-Disease Opportunity

The Global Autoimmune Hepatitis Market is estimated at USD 183.99 million in 2025 and is projected to reach USD 228.13 million by 2032, exp... Read More

Published Date: JUL-2026 | No Of Pages:197 | $ 4485

Xenotransplantation Market By Product Type (Solid Organs [Kidney, Heart, Liver], Cellular & Tissue Transplants); By Application (End-Stage Organ Failure, Regenerative/Immunotherapy Applications); By End User (Hospitals & Transplant Centers, Research Institutes, Cellular Therapy Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Xenotransplantation Market projected to reach USD 2.7 billion by 2030 from USD 1.2 billion in 2024, registering 13.5% CAGR, supported by clinical ... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Peptide and Anticoagulant Drugs Market By Product Type (Peptide-based Therapies, Anticoagulants); By Application (Cardiovascular, Oncology, Neurology, Endocrine & Metabolic Disorders); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers [ASCs], Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peptide And Anticoagulant Drugs Market valued at USD 18.3 billion in 2024 and projected to reach USD 32.1 billion by 2030 at 6.5% CAGR, driven by ... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Vaginal Anti-Infectives Market By Product Type (Antifungal Agents, Antibacterial Formulations, Antiseptics, Probiotic-Based Products); By Infection Type (Bacterial Vaginosis, Vulvovaginal Candidiasis, Trichomoniasis, Mixed Infections); By Route of Administration (Topical, Oral, Vaginal Tablets & Suppositories); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vaginal Anti-Infectives Market is projected to grow steadily between 2024 and 2030, expanding from an estimated value of USD 3.1 billion in 2024 to nearly USD 4.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Uterotonic Agent Market By Product Type (Oxytocin-Based, Prostaglandins, Ergot Derivatives, Combination Therapies); By Route of Administration (Intravenous, Intramuscular, Oral, Sublingual); By End User (Hospitals, Maternity Clinics & Birthing Centers, Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Uterotonic Agent Market will witness a robust CAGR of 6.8 %, valued at USD 2.1 billion in 2024, and is ... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Telestroke Services Market By Service Type (Ischemic Stroke Management, Hemorrhagic Stroke Management); By Component (Hardware, Software, Services); By Mode of Delivery (Web-Based, Cloud-Based, On-Premise); By End User (Hospitals, Telehealth Providers, Government & Public Health Agencies, Ambulatory & Specialty Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Telestroke Services Market valued at USD 1.6 billion in 2024 and projected to reach USD 2.9 billion by 2030 at 8.5% CAGR, driven by telemedicineRead More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Sulfonylureas Market By Drug Type (First-Generation Sulfonylureas [Tolbutamide, Chlorpropamide], Second-Generation Sulfonylureas [Glimepiride, Gliclazide, Glipizide, Glyburide]); By Therapy Type (Monotherapy, Combination Therapy [Metformin, DPP-4 Inhibitors]); By Formulation (Immediate-Release Tablets, Modified-Release Tablets); By Application (Type 2 Diabetes Mellitus, Neonatal Diabetes Mellitus); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

How Are Affordable Diabetes Medicines and Combination Treatments Sustaining the Sulfonylureas Market? – (Updated On: 8th-Oct-2026)

The Global Sulfonylureas Market was valued at USD 3.27 billion in 2025 and is projected to reach USD 3.81 billion by 2032, gro... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Submental Fat Treatment Market By Treatment Modality (Injectables, Cryolipolysis, Laser, Radiofrequency, Surgical Liposuction); By End User (Dermatology Clinics, Plastic Surgery Centers, Medspas, Specialized Aesthetic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Submental Fat Treatment Market is projected to witness a robust CAGR of 12.1%, valued at USD 1.1 billion in 2024 and expected to reach USD 2.1 billion by 2030,Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Proctoscope Market By Product Type (Disposable Proctoscopes, Reusable Proctoscopes); By Illumination Type (LED-Illuminated, Fiber-Optic, Non-Illuminated); By Application (Hemorrhoid Diagnosis, Anal Fissure & Fistula Management, Rectal Polyp & Tumor Detection); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Proctoscope Market is projected to grow steadily at a CAGR of 5.6% , valued at around USD 412 million in 2024 , and estimated to reach Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Pleural Effusion Market By Type (Transudative Effusion, Exudative Effusion); By Treatment (Thoracentesis, Indwelling Pleural Catheter, Pleurodesis, Pharmacologic Management); By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pleural Effusion Market is projected to reach USD 1.82 billion by 2030 , rising from an estimated USD 1.25 billion in 2024 , expanding at a CAGR o... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Pericarditis Treatment Market By Treatment Type (Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, IL-1 Inhibitors, Immunosuppressive Therapies, Intravenous Immunoglobulin, Other Supportive Therapies); By Application (Acute Pericarditis, Recurrent Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Post-Pericardiotomy Syndrome); By End User (Hospitals, Specialty Cardiology Centers, Ambulatory Care Centers, Specialty Clinics, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Pericarditis Treatment Market: Recurrent Disease Shifts Revenue Toward Long-Duration Specialty Care

The Global Pericarditis Treatment Market was valued at USD 3.30 billion in 2025 and is projected to reach USD 5.41 billion by 2032, growing at a CAGR of 6.4%, according... Read More

Published Date: JUL-2026 | No Of Pages:191 | $ 4485

Optogenetics Market By Product Type (Channelrhodopsins, Halorhodopsins, Archaerhodopsins, Red-Shifted Opsins); By Light Source (Laser Systems, LED Systems, Fiber Optics, Wireless Optical Devices); By Application (Neuroscience, Retinal Disorders, Cardiology, Psychiatric and Behavioral Research); By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, Clinical and Translational Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Optogenetics Market valued at USD 780 million in 2024 and projected to reach USD 1.78 billion by 2030 at 14.8% CAGR, driven by neuroscience resear... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Ophthalmology Electronic Health Record (EHR) Market By Product Type (Cloud-Based, On-Premise); By Application (Retina Management, Glaucoma Management, Cataract Surgery Tracking, Corneal Diagnostics, Optometry Records); By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmology Electronic Health Record (EHR) Market will grow at a robust CAGR of 8.1% , valued at around USD 1.7 billion in 2024 and projected to reach n... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Onchocerciasis Treatment Market By Drug Class (Macrocyclic Lactones, Antibiotics, Anti-Wolbachia Agents); By Treatment Strategy (Mass Drug Administration, Selective/Targeted Treatment); By Distribution Model (Donation-Based, Government Procurement, NGO-Driven); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Onchocerciasis Treatment Market is poised to grow at a CAGR of 5.6% , rising from an estimated USD 297.5 million in 2024 to approximately... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Neuraminidase Inhibitors Market By Product Type (Oseltamivir, Zanamivir, Peramivir, Next-Generation Long-Acting Inhibitors); By Route of Administration (Oral, Inhalation, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Supply Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Neuraminidase Inhibitors Market Benefits from Seasonal Influenza Treatment Demand and Antiviral Stockpile Readiness (Last Updated On: June-2026)

The Global Neuraminidase Inhibitors Market was valued at USD 4.6 billion in 2024 and is projected to reach USD 7.1 bil... Read More

Published Date: Jun-2026 | No Of Pages:195 | $ 4485

Nerve Growth Factor Market By Product Type (Recombinant NGF Proteins, Natural NGF Extracts, Gene Therapy Vectors); By Application (Neurodegenerative Disorders, Ophthalmology, Wound Healing, Peripheral Nerve Regeneration); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Specialty Clinics, Contract Research & Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nerve Growth Factor Market valued at USD 3.2 billion in 2024 and projected to reach USD 5.1 billion by 2030 at 8.1% CAGR, driven by neurodege... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Nasal Polyposis Treatment Market By Treatment Type (Intranasal Corticosteroids, Oral Corticosteroids, Biologics, Endoscopic Sinus Surgery, Supportive Therapies); By Disease Severity (Mild to Moderate CRSwNP, Severe Uncontrolled CRSwNP); By Biologic Class (IL-4/IL-13 Inhibitors, Anti-IgE Therapy, IL-5 Inhibitors, TSLP Inhibitors, Other Pipeline Biologics); By End User (Hospitals, ENT Specialty Clinics, Allergy & Pulmonology Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Nasal Polyposis Treatment Market Benefits from Severe CRSwNP Biologic Expansion and Steroid-Sparing Treatment Demand

The Global Nasal Polyposis Treatment Market was valued at USD 4.94 billion in 2025 and is projected to reach USD 7.79 billion by 2032, growing at a CAG... Read More

Published Date: JUL-2026 | No Of Pages:198 | $ 4485

Mitotic Inhibitors Market By Drug Class (Vinca Alkaloids, Taxanes, Others); By Application (Breast Cancer, Lung Cancer, Ovarian Cancer, Leukemia & Lymphoma, Other Solid Tumors); By Route of Administration (Intravenous, Oral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Mitotic Inhibitors Market: Established Oncology Use, Generic Expansion, and Emerging Mitotic-Targeted Therapies (Last Updated on: June-2026)

The Global Mitotic Inhibitors Market is projected to expand at a CAGR of 5.9%, with an estimated valua... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Meglitinides Market By Molecule Type (Repaglinide, Nateglinide); By Formulation (Monotherapy Tablets, Fixed-Dose Combinations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Meglitinides Market is projected to reach USD 754 million by 2030 , up from an estimated USD 520 million in 2024 , growing at a C... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Lysosomal Enzymes Market By Type (Acid Hydrolases, Proteases, Glycosidases, Lipases); By Disease Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis [MPS I, II, VI], Others); By Source (Human Recombinant Systems, Animal Cell Culture, Microbial Expression Systems); By End User (Pharmaceutical & Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals & Clinical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lysosomal Enzymes Market is projected to register a steady CAGR of 6.5% , valued at around USD 7.8 billion in 2024 and expected to reach nearly USD 12.1 billion by... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Leukotriene Inhibitors Market By Drug Type (Montelukast, Zafirlukast, Pranlukast, Others); By Application (Asthma, Allergic Rhinitis, Chronic Urticaria, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leukotriene Inhibitors Market is projected to grow at a steady pace, rising from an estimated USD 1.62 billion in 2024 to approximately USD 2.31 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Keratolytic Agents Market By Product Type (Salicylic Acid, Urea, Alpha Hydroxy Acids, Lactic Acid, Sulfur Compounds, Others); By Formulation Type (Topical Creams & Ointments, Gels & Serums, Medicated Shampoos, Patches & Plasters, Liquid Solutions & Peels); By Application (Dermatological Disorders, Cosmetic Exfoliation & Skincare, Wart & Callus Removal, Foot Care, Scalp and Hair Treatment, Veterinary & Niche Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Keratolytic Agents Market is projected to expand at a CAGR of 5.8% , rising from an estimated $1.12 billion in 2024 to reach approximately $1.58 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Polyclonal Antibodies Market By Source (Rabbit, Goat, Sheep, Others); By Application (Research, Diagnostics, Therapeutics, Veterinary); By End User (Academic & Research Institutes, Pharmaceutical & Biotech Companies, Diagnostics Manufacturers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Polyclonal Antibodies Market valued at USD 2.34 billion in 2024 and projected to reach USD 3.3 billion by 2030 at 5.9% CAGR, driven by biopharmace... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Uterine Fibroid Embolization Devices Market By Product Type (Embolic Agents, Microcatheters, Guidewires, Delivery Syringes); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Office-Based Labs); By Patient Profile (Women aged 30–50, Fertility-Preserving Candidates, High-Risk Surgical Patients); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Uterine Fibroid Embolization Devices Market is projected to grow at a CAGR of 8.6%, valued at USD 1.2 billion in 2024, and expected to reach USD 2... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Organ Function Assays Market By Test Type (Liver Function Tests, Renal Function Tests, Cardiac Function Tests, Pulmonary Function Tests, Thyroid Function Tests); By Technology (Immunoassays, Chemiluminescence & Colorimetric Assays, Enzymatic & Spectrophotometric, Point-of-Care Devices); By End User (Hospitals & Clinical Labs, Ambulatory Surgical Centers, Diagnostic Chains, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Organ Function Assays Market will witness a steady CAGR of 6.5%, valued at USD 4.1 billion in 2024, and projected to reach USD 6.0 billion by 2030, accord... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Stereotactic X-ray Market By Technology Type (Frame-Based Stereotactic Systems, Frameless Image-Guided Systems); By Application (Oncology, Functional Neurosurgery, Spinal Interventions, Pain Management, Biopsy and Localization); By End User (Hospitals and Academic Centers, Specialty Cancer Centers, Outpatient Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stereotactic X-Ray Market is projected to grow at a steady pace, expected to reach USD 2.1 billion by 2030, up from USD 1.4 billion in 2024, reflecting a CAGR of 6... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Emergency Escape Breathing Device Market By Product Type (Hooded EEBDs, Full-Face Mask Devices, Mouthpiece-Only Devices); By End User (Maritime & Offshore, Industrial Manufacturing, Mining & Tunneling, Public Infrastructure & Commercial Buildings, Emergency Services); By Duration (Short-Duration EEBDs, Medium-Duration EEBDs, Extended-Duration EEBDs); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Emergency Escape Breathing Device Market: Safeguarding Lives in Critical Industrial Environments

The Global Emergency Escape Breathing Device Market was valued at USD 1.19 billion in 2025 and is projected to reach USD 2.10 billion by 2032, exp... Read More

Published Date: AUG-2026 | No Of Pages:166 | $ 4485

Reporter Tags Market By Tag Type (Fluorescent Tags, Enzymatic Tags, Epitope Tags, Radioactive & Chemiluminescent Tags); By Application (Gene Expression Analysis, Drug Screening, Protein Localization, Synthetic Biology, Biomarker Discovery); By End User (Academic & Research Institutes, Biotech & Pharma Companies, CROs, Diagnostic Developers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Reporter Tags Market valued at USD 880 million in 2024 and projected to reach USD 1.46 billion by 2030 at 8.7% CAGR, driven by biotechnology resea... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Pelvic Organ Prolapse Repair Market By Product Type (Synthetic Mesh, Biologic Implants, Pessaries, Suturing Kits); By Procedure Type (Vaginal Repair, Laparoscopic Repair, Robotic-Assisted Repair, Abdominal Repair); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, OB-GYN Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pelvic Organ Prolapse Repair Market valued at USD 2.1 billion in 2024 and projected to reach USD 3.4 billion by 2030 at 8.3% CAGR, driven by pelvi... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Inactivated Vaccines Market By Vaccine Type (Whole Virus Inactivated, Split/Subunit, Toxoid); By Indication (Polio, Hepatitis A, Rabies, Influenza, Combination Vaccines); By End User (Public Health Programs, Pediatric Clinics, Travel Clinics, Military & Occupational Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inactivated Vaccines Market projected to reach USD 33.7 billion by 2030 from USD 22.7 billion in 2024, registering 6.8% CAGR, supported by vaccina... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Saphenous Vein Grafts Market By Application (Coronary Artery Bypass Grafting, Peripheral Vascular Bypass, Carotid Endarterectomy Support); By Harvesting Technique (Open Vein Harvesting, Endoscopic Vein Harvesting); By End User (Hospitals, Cardiac Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Saphenous Vein Grafts Market is projected to expand at a steady pace, with an estimated valuation of USD 543.7 million in 2024, and anticipated to reach around USD... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Aldose Reductase Inhibitor Market By Drug Type (Epalrestat, Ranirestat, Fidarestat, Investigational ARIs); By Application (Diabetic Neuropathy, Diabetic Retinopathy, Diabetic Nephropathy, Others); By Route of Administration (Oral, Topical, Injectable); By End User (Hospitals, Specialty Clinics, Diabetic Care Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aldose Reductase Inhibitor Market will witness a steady CAGR of 7.9%, valued at USD 610.0 million in 2024, and expected to reach around <... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Spinal Machined Bone Allograft Market By Graft Type (Cervical Machined Allograft, Thoracolumbar Machined Allograft); By Shape & Preparation (Blocks, Wedges, Plugs, Cages; Freeze-Dried, Fresh-Frozen, Carrier-Based); By End User (Hospitals, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Machined Bone Allograft Market will expand at a projected CAGR of 6.7%, reaching an estimated USD 1.96 billion by 2030, up from USD 1.31 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Archaeosomes Market By Product Type (Synthetic Archaeosomes, Natural Archaeosomes); By Application (Vaccine Delivery, Cancer Immunotherapy, Gene Therapy, Oral Drug Delivery, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CDMOs, Government & Nonprofit Research Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Archaeosomes Market is poised for steady growth, with an estimated value of USD 143.7 million in 2024, projected to reach USD 271.2 million by 203... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Blocking Buffers Market By Type (Protein-Based, Synthetic, Serum-Based/Hybrid); By Application (Western Blotting, ELISA, Immunohistochemistry, Flow Cytometry); By End User (Academic & Research Institutes, Biotech & Pharma Companies, CROs, Clinical Diagnostics Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blocking Buffers Market will grow at a steady CAGR of 6.5%, valued at USD 1.2 billion in 2024 and projected to reach USD 1.77 billion by 2030, according t... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Radiation Proctitis Market By Treatment Type (Medications, Endoscopic Therapies, Surgical Interventions); By Route of Administration (Oral, Rectal, Intravenous); By End User (Hospitals & Specialty Oncology Centers, Outpatient Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radiation Proctitis Market will witness a steady CAGR of 5.9%, valued at $494 million in 2024, expected to reach $701 million by 2030, confirms St... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Cardiovascular Genetic Testing Market By Test Type (Single-Gene Testing, Multi-Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing); By Application (Cardiomyopathies, Channelopathies, Aortic Disorders, Familial Hypercholesterolemia, Congenital Heart Disease, Sudden Cardiac Death Risk); By End User (Hospitals & Cardiology Clinics, Diagnostic Laboratories, Academic & Research Institutions, Direct-to-Consumer Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Genetic Testing Market will witness a strong CAGR of 11.7%, valued at USD 2.6 billion in 2024, and is expected to reach around USD 5.1 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Predictive Genetic Counselling Market By Service Type (In-Person Counselling, Tele-genetic Counselling, Hybrid Models); By Application (Oncology, Cardiovascular, Neurogenetics, Reproductive & Carrier Screening); By End User (Hospitals & Academic Centers, Oncology Clinics, Fertility Clinics, Primary Care, Diagnostic Labs, DTC Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Predictive Genetic Counselling Market is positioned for a steady expansion through 2030, the market is projected to grow at a compound annual growth rate (CAGR) of 9.6%, r... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Desalting and Buffer Exchange Market By Product Type (Columns, Membrane Filters, Centrifugal Devices, Pre-packed Systems); By Technique (Gel Filtration, Ultrafiltration, Dialysis); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutes, Diagnostic Manufacturers); By Application (Protein Purification, Antibody Formulation, Viral Vector Preparation, Diagnostic Assay Development); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Desalting And Buffer Exchange Market is poised for steady expansion through 2030, registering an estimated CAGR of 6.8%. The market is projected to reach ... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Epitope Tags Market By Tag Type (His-tag, FLAG-tag, HA-tag, c-Myc, V5, Custom Tags); By Application (Protein Purification, Detection & Localization, Protein-Protein Interaction Studies, Therapeutic Development, Vaccine R&D); By End User (Academic & Research Institutes, Biopharmaceutical Companies, CROs/CDMOs, Diagnostic Developers, Synthetic Biology Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Epitope Tags Market is estimated to reach a value of USD 408.6 million in 2024, and is projected to grow steadily to about USD 692.1 million by 2030, marking a CAG... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Intracranial Aneurysm Market By Type (Ruptured Aneurysm, Unruptured Aneurysm); By Treatment (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others); By End User (Hospitals and Neurosurgery Centers, General Hospitals, ASCs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intracranial Aneurysm Market valued at USD 2.4 billion in 2024 and projected to reach USD 3.8 billion by 2030 at 8.1% CAGR, driven by neurovascula... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Inotropic Agents Market By Drug Type (Positive Inotropes, Negative Inotropes); By Route of Administration (Intravenous, Oral); By Application (Heart Failure, Cardiogenic Shock, Myocardial Infarction, Perioperative Cardiac Support); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inotropic Agents Market is projected to witness a steady expansion between 2024 and 2030, growing at an CAGR of 5.8%. The market, valued at around USD 2.9 billion ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Incretin Mimetics Market By Drug Class (GLP-1 Receptor Agonists, Dual Incretin Agonists [GLP-1/GIP], Triple Agonists [GLP-1/GIP/Glucagon]); By Route of Administration (Injectable, Oral); By Application (Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, NASH & Metabolic Disorders); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Incretin Mimetics Market is projected to experience steady expansion between 2024 and 2030, according to Strategic Market Research . The market is valued at approximately USD 18.6 ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Hyperthyroidism Market By Treatment Type (Antithyroid Drugs, Radioactive Iodine Therapy, Surgery, Beta-Blockers); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyperthyroidism Market is projected to grow at a CAGR of 7.3% , climbing from an estimated USD 1.9 billion in 2024 to nearly USD 2.9 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Hypereosinophilic Syndrome Market By Drug Class (Corticosteroids, IL-5 Inhibitors, Tyrosine Kinase Inhibitors, Others); By Route of Administration (Oral, Subcutaneous, Intravenous); By End User (Specialty Clinics, Hospitals, Academic Medical Centers); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Hypereosinophilic Syndrome Market is projected to grow at a steady CAGR of 6.3%, reaching an estimated valuation of USD 1.7 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Glycopeptide Antibiotics Market By Product Type (Vancomycin, Teicoplanin, Lipoglycopeptides [Dalbavancin, Oritavancin, Telavancin]); By Route of Administration (Intravenous, Oral); By Indication (MRSA Infections, CDI, Bloodstream & Sepsis, SSTIs, Bone & Joint Infections); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Glycopeptide Antibiotics Market is projected to grow steadily at an estimated CAGR of 6.1% , reaching approximately USD 3.2 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Gemcitabine Hydrochloride Market By Application (Pancreatic Cancer, Non-Small Cell Lung Cancer, Bladder Cancer); By Dosage Form (Lyophilized Powder for Injection, Ready-to-Use Injectable Solution, Concentrated Solution for Injection); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Other Distribution Channels); By End User (Hospitals, Cancer Treatment Centers, Ambulatory Infusion Centers); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

How Are Expanding Cancer Treatment Requirements and Advances in Injectable Chemotherapy Shaping the Global Gemcitabine Hydrochloride Market?  – (Updated On: 28th-Oct-2026)

The Global Gemcitabine Hydrochloride Market was valued at USD 252.08 million in ... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Lung Surfactants Market By Type (Natural Surfactants, Synthetic Surfactants); By Delivery Method (Intratracheal Instillation, LISA, Nebulized/Aerosolized); By Application (Neonatal RDS, Meconium Aspiration Syndrome, Pulmonary Hemorrhage, Adult ARDS); By End User (Tertiary Hospitals, General Hospitals, Private Maternity Clinics, Government/NGO Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lung Surfactants Market is expected to expand at a steady CAGR of 6.9%, reaching an estimated size of USD 1.78 billion by 2030, up from USD 1.19 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Spinal Allografts Market By Product Type (Structural Grafts, Non-Structural Grafts); By Application (Degenerative Spine, Trauma, Deformities, Revision Surgeries); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Allografts Market valued at USD 3.2 billion in 2024 and projected to reach USD 5.0 billion by 2030 at 6.8% CAGR, driven by spinal fusionRead More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Endothelin Antagonists Therapeutics Market By Drug Type (Selective ETA Antagonists, Dual ETA/ETB Antagonists); By Application (Pulmonary Arterial Hypertension [PAH], Chronic Kidney Disease & Diabetic Nephropathy, Systemic Sclerosis and Fibrosis Disorders); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endothelin Antagonists Therapeutics Market is projected to grow steadily at a CAGR of 6.8%, valued at USD 2.3 billion in 2024 and anticipated to reach Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Cell Cycle Inhibitors Market By Drug Class (CDK4/6 Inhibitors, Aurora Kinase Inhibitors, WEE1 Inhibitors, CHK1/2 Inhibitors, Multi-Target Inhibitors); By Cancer Type (Breast Cancer, Lung Cancer, Ovarian Cancer, Glioblastoma, Hematologic Malignancies, Others); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Cell Cycle Inhibitors Market Intelligence Snapshot (Last Updated on: June-2026)

The Global Cell Cycle Inhibitors Market is poised for steady expansion, expected to register a CAGR of 6.8%, rising from USD 5.3 billion in 2... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Dental Fluoride Treatment Market By Product Type (Fluoride Varnishes, Fluoride Gels, Fluoride Foams, Prescription-Strength Toothpaste, Prescription-Strength Gels, Prescription-Strength Mouthrinses); By Delivery Format (Unit-Dose Cups, Single-Patient Blister Packs, Multidose Tubes, Applicator-Based Formats, Tray-Based Applications); By Patient Group (Children, Adolescents, Adults, Older Adults, High-Caries-Risk Patients); By End User (Dental Practices, Pediatric Dental Clinics, Primary-Care Settings, Community Oral-Health Programs, School-Based Dental Programs, Hospitals and Public Dental Services); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Dental Fluoride Treatment Market: Repeat Preventive Applications Create Recurring Consumable Demand

The Global Dental Fluoride Treatment Market was valued at USD 12.95 billion in 2025 and is projected to reach USD 19.65 billion by 2032, growing at a CAGR of 6.14%, acc... Read More

Published Date: JUL-2026 | No Of Pages:164 | $ 4485

Ear Infection Treatment Market By Product Type (Antibiotics, Antifungals, Analgesic and Anaesthetic Ear Drops, Antibiotic–Corticosteroid Combinations, Other Supportive Treatments); By Application (Acute Otitis Media, Recurrent Otitis Media, Acute Otitis Externa, Chronic Suppurative Otitis Media, Fungal Otitis Externa); By End User (Hospitals, ENT Clinics, Pediatric and Primary Care Clinics, Community and Retail Pharmacies, Other Healthcare Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Ear Infection Treatment Market: Pharmacy Access, Stewardship, and Specialty Otic Products Reshape Commercial Value

The Global Ear Infection Treatment Market was valued at USD 13.63 billion in 2025 and is projected to reach USD 21.18 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:197 | $ 4485

Nasal Packing Devices Market By Product Type (Absorbable Packs, Non-Absorbable Packs, Balloon Catheters, Hemostatic Dressings); By Application (Epistaxis Management, Postoperative Hemostasis, Trauma-Related Bleeding Control); By End User (Hospitals, Ambulatory Surgical Centers, Emergency Care Clinics); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Nasal Packing Devices Market: Bioresorbable Technologies Reshape Epistaxis Control and Postoperative ENT Care

The Global Nasal Packing Devices Market was valued at USD 208.5 million in 2025 and is projected to reach USD 309.4 million by 2032, growing at a CAGR of 5.8%... Read More

Published Date: AUG-2026 | No Of Pages:166 | $ 4485

Necrobiosis Lipoidica Market By Treatment Type (Corticosteroids, Immunomodulators, Biologic Therapies, Antiplatelet and Vasodilator Therapies, Phototherapy, Wound Care and Supportive Treatment, Others); By Route of Administration (Topical, Oral, Intralesional, Injectable); By Disease Presentation (Non Ulcerated Necrobiosis Lipoidica, Ulcerated Necrobiosis Lipoidica); By End User (Hospitals, Dermatology Clinics, Specialty Clinics, Ambulatory and Outpatient Care Centers, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

What Is the Necrobiosis Lipoidica Market Size and How Is the Therapeutic Landscape Changing?  – (Updated On: 24-Aug-2026)

The Global Necrobiosis Lipoidica Market was valued at USD 190 million in 2025 and is projected to reach USD 282 million by 2032, e... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Mitogen-Activated Protein Kinase (MAPK) Inhibitors Market By Inhibitor Type (BRAF Inhibitors, MEK Inhibitors, ERK Inhibitors, Multi-Kinase Inhibitors); By Application (Oncology, Inflammatory Disorders, Rare Genetic Syndromes); By Route of Administration (Oral, Intravenous); By End User (Hospitals & Oncology Centers, Academic & Research Institutions, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitogen - Activated Protein Kinase ( MAPK ) Inhibitors Market will witness a robust CAGR of 9.8... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Antiplatelet Drugs Market By Product Type (Aspirin, Thienopyridine P2Y12 Inhibitors, Non-Thienopyridine P2Y12 Inhibitors, Glycoprotein IIb/IIIa Inhibitors, Phosphodiesterase Inhibitors, PAR-1 Antagonists, Combination Therapies); By Route of Administration (Oral, Injectable); By Application (Acute Coronary Syndrome, Ischemic Stroke & TIA Prevention, Peripheral Artery Disease, Percutaneous Coronary Intervention Support, Others); By End User (Hospitals, Cardiology Clinics, Retail Pharmacies & Online Platforms, Specialized Cardiovascular Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Antiplatelet Drugs Market: ACS Guidelines, Stroke Prevention, PAD Burden, and Reversal-Agent Innovation Reshape Cardiovascular Thrombosis Care

The Global Antiplatelet Drugs Market was valued at USD 3.16 billion in 2025 and is projected to reach USD 4.91 billion by 203... Read More

Published Date: JUN-2026 | No Of Pages:196 | $ 4485

Disseminated Intravascular Coagulation Market By Product Type (Therapeutics, Diagnostic Assays, Supportive Care Solutions); By Application (Sepsis, Trauma, Oncology, Obstetric Complications); By End User (Hospitals, Specialized Diagnostic Laboratories, Critical Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Disseminated Intravascular Coagulation ( DIC ) Market is projected to witness a robust CAGR of 6.8%, valued at U... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Hemophagocytic Lymphohistiocytosis (HLH) Market By Type (Acquired/Secondary HLH [Infection-Associated HLH, Malignancy-Associated HLH, Autoimmune-Associated HLH/Macrophage Activation Syndrome], Familial/Primary/Genetic HLH [FHL1, FHL2/PRF1, FHL3/UNC13D, FHL4/STX11, FHL5/STXBP2]); By Treatment (Chemotherapy & Immunotherapy, Targeted Biological & Novel Therapies, Hematopoietic Stem Cell Transplantation [HSCT], Steroids, Antiviral & Antibiotic Drugs); By Diagnosis (Blood Tests, Genetic Testing, Bone Marrow Biopsy/Aspiration, Infectious Disease & Flow Cytometry Workups); By Route of Administration (Injectable Therapies, Oral Therapies); By Distribution Channel (Hospital Pharmacies, Online & Specialty Pharmacies, Retail Pharmacies); By End User (Hospitals, Specialty Cancer, Hematology, Immunology & Rare Disease Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Why Are Precision Diagnostics and Targeted Immune Therapies Redefining the Hemophagocytic Lymphohistiocytosis (HLH) Market? – (Updated On: 6th-Oct-2026)

The Global Hemophagocytic Lymphohistiocytosis (HLH) Market was valued at USD 1.37 billion in 2025 and is... Read More

Published Date: JAN-2026 | No Of Pages:174 | $ 4485

Frozen Shoulder Treatment Market By Treatment Type (Physical Therapy and Rehabilitation, Corticosteroid Injections, Hydrodilatation, Pain Management Medications, Suprascapular Nerve Blocks, Manipulation Under Anesthesia, Arthroscopic Capsular Release, Transarterial Embolization); By Application (Primary Frozen Shoulder, Diabetes-Associated Frozen Shoulder, Post-Surgical Frozen Shoulder, Post-Traumatic Frozen Shoulder, Refractory Frozen Shoulder); By End User (Hospitals, Orthopedic Clinics, Physiotherapy and Rehabilitation Centers, Sports Medicine Clinics, Diagnostic and Interventional Radiology Centers, Ambulatory Surgical Centers, Pain Management Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Frozen Shoulder Treatment Market: Injection-Led Care and Hydrodilatation Keep Surgery Selective

The Global Frozen Shoulder Treatment Market was valued at USD 1.28 billion in 2025 and is projected to reach USD 1.99 billion by 2032, growing at a... Read More

Published Date: JUL-2026 | No Of Pages:200 | $ 4485

Fibroblast Activation Protein (FAP) Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Antibody-Based Inhibitors, Radiopharmaceutical Conjugates); By Therapeutic Indication (Oncology, Fibrotic Diseases); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Cancer and Specialty Hospitals, Academic & Research Institutions, Diagnostic Imaging Centers, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Fibroblast Activation Protein (FAP) Inhibitors Market is estimated to be valued at USD 820 million in 2024 and is projected to reach around USD 1.45 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Fibrate Drugs Market By Drug Type (Fenofibrate, Gemfibrozil, Bezafibrate, Ciprofibrate, Pemafibrate); By Route of Administration (Oral, Parenteral [Experimental]); By Indication (Hypertriglyceridemia, Mixed Dyslipidemia, Cardiovascular Disease Prevention); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibrate Drugs Market valued at USD 2.9 billion in 2024 and projected to reach USD 4.1 billion by 2030 at 5.8% CAGR, driven by lipid lowering drugs... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Eye Drops and Lubricants Drugs Market By Product Type (Artificial Tears, Lipid-Based Lubricants, Anti-inflammatory Eye Drops, Preservative-Free Formulations, Nanoemulsion-Based Systems); By Therapeutic Indication (Dry Eye, Post-Surgical Recovery, Allergic Conjunctivitis, Meibomian Gland Dysfunction, Contact Lens Discomfort); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Eye Drops And Lubricants Drugs Market is projected to grow at a steady CAGR of 7.1% , reaching approximately USD 6.2 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Expectorant Drugs Market By Drug Type (Synthetic Expectorants, Natural/Herbal Expectorants); By Formulation (Syrup, Tablet, Capsule, Extended-Release); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By End User (Hospitals, Clinics, Homecare Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Expectorant Drugs Market is projected to grow at a steady CAGR of around 5.8% , valued at USD 7.9 billion in 2024 and anticipated to reach nearly USD 11.1 billion ... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Estrogen Receptor Modulators Market By Drug Class (Selective Estrogen Receptor Modulators, Selective Estrogen Receptor Degraders, Estrogen Receptor Antagonists, Targeted Protein Degraders); By Product (Tamoxifen, Raloxifene, Clomiphene, Toremifene, Fulvestrant, Elacestrant, Imlunestrant, Vepdegestrant, Camizestrant, Other Estrogen Receptor Modulators); By Route of Administration (Oral, Injectable); By Application (Breast Cancer Treatment, Osteoporosis Management, Breast Cancer Risk Reduction, Fertility and Ovulation Induction, Gynecological and Menopausal Applications); By End User (Hospitals, Specialty Oncology Clinics, Fertility Clinics, Retail Pharmacies, Specialty Pharmacies, Academic and Clinical Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Estrogen Receptor Modulators Market: Precision Endocrine Therapies Reshaping Breast Cancer, Bone Health, and Reproductive Medicine

The Global Estrogen Receptor Modulators Market was valued at an estimated USD 4.72 billion in 2025 and is projected to reach USD 9.08 bil... Read More

Published Date: AUG-2026 | No Of Pages:175 | $ 4485

Cough Suppressant Market By Product Type (Pharmaceutical-based, Herbal/Natural, Combination); By Route of Administration (Syrups, Lozenges, Capsules, Sprays); By Age Group (Pediatrics, Adults, Geriatrics); By Distribution Channel (Retail Pharmacies, Online Platforms, Hospitals & Clinics, Wellness Stores); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

 Introduction And Strategic Context

The Global Cough Suppressant Market valued at USD 6.9 billion in 2024 and projected to reach USD 9.7 billion by 2030 at 5.8% CAGRRead More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Congestive Renal Failure Market By Product Type (Therapeutics, Dialysis Systems, Diagnostics & Monitoring Devices); By Application (Chronic Management, Acute Intervention); By End User (Hospitals, Specialty Renal Centers, Ambulatory & Outpatient Clinics, Home Healthcare, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congestive Renal Failure Market is poised to witness a robust CAGR of 7.2 %, valued at around USD 12.6 billion in 2024 , and expected to ... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Chronic Ocular Surface Pain Market By Pain Mechanism (Nociceptive, Neuropathic); By Therapeutic Class (Anti-Inflammatories, Neuropathic Modulators, TRP/Sodium Channel Blockers, Regenerative Therapies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Ocular Surface Pain Market is estimated to be worth USD 1.1 billion in 2024 , with expectations to reach USD 1.75 billion by 2030 , expanding at a steady C... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Cephalosporin Drugs Market By Generation (First, Second, Third, Fourth, Fifth); By Route of Administration (Oral, Parenteral); By Application (Respiratory, Skin & Soft Tissue, Urinary Tract, Gastrointestinal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cephalosporin Drugs Market is projected to grow steadily at a CAGR of 4.9% between 2024 and 2030 , with an estimated valuation of USD 15.6 billion... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Calcium Channel Blocker Market By Drug Class (Dihydropyridines, Non-Dihydropyridines); By Application (Hypertension, Angina, Arrhythmias, Others); By End User (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Calcium Channel Blocker Market valued at USD 8.7 billion in 2024 and projected to reach USD 12.1 billion by 2030 at 5.4% CAGR, driven by cardiovas... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Calcimimetics Market By Drug Type (Cinacalcet, Etelcalcetide, Others); By Indication (Secondary Hyperparathyroidism, Primary Hyperparathyroidism, Parathyroid Carcinoma, Others); By Route of Administration (Oral, Intravenous); By End User (Dialysis Centers, Hospitals, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Calcimimetics Market is forecast to grow at a steady CAGR of 6.1% , rising from approximately USD 872.5 million in 2024 to reach an estim... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Bone Resorption Inhibitors Market By Product Type (Bisphosphonates, Selective Estrogen Receptor Modulators [SERMs], Calcitonin, Monoclonal Antibodies); By Route of Administration (Oral, Parenteral [Subcutaneous, Intravenous]); By Application (Osteoporosis, Oncology-related Bone Disease, Rheumatologic Disorders, Endocrine-related Bone Loss); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Ambulatory Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Bone Resorption Inhibitors Market valued at USD 11.2 billion in 2024 and projected to reach USD 15.7 billion by 2030 at 5.8% CAGR, driven by osteo... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Benzodiazepine Drugs Market By Drug Type (Short-Acting, Long-Acting); By Application (Anxiety, Insomnia, Seizures, Alcohol Withdrawal, Preoperative Sedation); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Benzodiazepine Drugs Market valued at USD 4.3 billion in 2024 and projected to reach USD 5.4 billion by 2030 at 3.9% CAGR, driven by anxiety treat... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Bacterial Vaccines Market By Vaccine Type (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Subunit & Recombinant Vaccines); By Disease Indication (Pneumococcal, Pertussis, Meningococcal, Tuberculosis, Typhoid & Cholera, Others); By Route of Administration (Injectable, Oral, Intranasal); By End User (Hospitals & Clinics, Vaccination Centers, Travel & Occupational Health Providers, Government Immunization Programs, NGOs & Multilateral Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bacterial Vaccines Market valued at USD 25.6 billion in 2024 and projected to reach USD 42.1 billion by 2030 at 8.6% CAGR, driven by vaccine devel... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Artificial Ventilation and Anaesthesia Masks Market By Product Type (Reusable Masks, Disposable Masks, Specialty Masks); By Application (Surgical & Anaesthesia, Critical Care & ICU, Emergency & Pre-Hospital); By End User (Hospitals, Ambulatory Surgical Centers, Emergency Services, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Artificial Ventilation And Anaesthesia Masks Market will witness a robust CAGR of 7.5 %, valued at an USD 3.2 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Anxiolytics Market By Drug Class (Benzodiazepines, SSRIs, SNRIs, Azapirones [Buspirone], Antihistamines, Others [Neurosteroids, Cannabinoid-Based Compounds]); By Application (Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Post-Traumatic Stress Disorder, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Telemedicine Platforms); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

How Big Is the Anxiolytics Market and Which Therapies Are Shaping Its Next Phase of Growth?  – (Updated On: 07-Sep-2026)

The Global Anxiolytics Market was valued at USD 5.47 billion in 2025 and is projected to reach USD 8.03 billion by 2032, expanding ... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Antivertigo Agents Market By Drug Class (Antihistamines, Anticholinergics, Benzodiazepines, Beta Blockers & Calcium Channel Blockers, Others); By Route of Administration (Oral, Transdermal, Injectable, Intranasal & Sublingual); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antivertigo Agents Market is estimated to reach USD 2.7 billion in 2024 , and is projected to grow to USD 3.9 billion by 2030 , expanding... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Antitussive Drugs Market By Drug Type (Opioid-Based, Non-Opioid); By Formulation (Syrup, Tablets & Capsules, Lozenges & Sprays); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antitussive Drugs Market is projected to expand at an estimated CAGR of 4.8% , reaching around USD 6.9 billion by 2030 , up from approximately USD... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Antithyroid Agents Market By Drug Type (Methimazole, Propylthiouracil, Carbimazole); By Route of Administration (Oral, Liquid Formulations); By Disease Indication (Graves’ Disease, Toxic Multinodular Goiter, Thyroid Adenoma, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antithyroid Agents Market is estimated to be valued at USD 1.4 billion in 2024 , expected to reach USD 1.9 billion by 2030 , growing at a CAGR of around 5.1%Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Antispasmodics Drugs Market By Drug Class (Smooth Muscle Relaxants, Anticholinergics, Combination Therapies); By Application (Gastrointestinal Disorders, Urinary Tract Disorders, Menstrual Pain, Neuromuscular Spasms); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antispasmodics Drugs Market is projected to grow steadily at a CAGR of 5.6% , valued at USD 3.8 billion in 2024 and expected to reach nearly USD 5.3 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Antifibrinolytic Drugs Market By Product (Tranexamic Acid, Aminocaproic Acid, Aprotinin, Other Antifibrinolytic Drugs); By Formulation (Oral Tablets and Solutions, Conventional Injectable Vials and Ampoules, Ready-to-Use Intravenous Bags); By Application (Heavy Menstrual Bleeding, Orthopedic Surgery, Cardiovascular Surgery, Postpartum Haemorrhage, Trauma and Emergency Bleeding, Dental Procedures in Patients with Bleeding Disorders, Other Hyperfibrinolytic Bleeding Conditions); By End User (Hospitals and Surgical Centers, Maternity and Obstetric Care Facilities, Trauma and Emergency Care Centers, Specialty Clinics, Retail and Community Pharmacies, Government and Public-Health Procurement Programs); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Antifibrinolytic Drugs Market: Protocol-Led Tranexamic Acid Demand Shifts Competition from Molecule Supply to Safer Hospital Formats

The Global Antifibrinolytic Drugs Market is estimated at USD 1.91 billion in 2025 and ... Read More

Published Date: JUL-2026 | No Of Pages:173 | $ 4485

Antidotes Market By Product Type (Chemical Antidotes, Drug Overdose Antidotes, Biological/Enzymatic Antidotes); By Route of Administration (Intravenous, Oral, Intramuscular); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Emergency Supply Chains); By End User (Hospitals, Poison Control Centers, EMS, Military/Disaster Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antidotes Market valued at USD 4.2 billion in 2024 and projected to reach USD 6.2 billion by 2030 at 6.8% CAGR, driven by toxicology treatmentRead More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Aneurysm Clips Market By Material Type (Titanium, Cobalt-Chromium, Others); By Aneurysm Type (Saccular, Fusiform & Dissecting); By End User (Hospitals & Neurosurgical Centers, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneurysm Clips Market projected to reach USD 89.6 million by 2030 from USD 62.8 million in 2024, registering 6.1% CAGR, supported by neurosurgical... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Antiretroviral Therapy Market By Drug Class (NRTIs, NNRTIs, INSTIs, Protease Inhibitors, Entry Inhibitors); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online, Public Supply); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Global Antiretroviral Therapy (ART) Market Structure: High Coverage, Persistent Pediatric Gap, and Prevention Expansion

The Global Antiretroviral Therapy (ART) Market valued at USD 34.7 billion in 2025 and projected to reach USD 55.4 billion by 2032, growing at a... Read More

Published Date: JUN-2026 | No Of Pages:154 | $ 4485